Gd.DOTA.DSA liposomes enhance tumor MRI signal via EPR accumulation, reducing liver toxicity.
Alanylglutamine composition resolves solubility and stability trade-offs to enhance concentration via optimized parameter changes.
Antimicrobial peptides strengthen immature gut and lung barriers, reducing necrotizing enterocolitis risk.
A dry flowable composition prevents agglomeration and foam by using a water-soluble sugar carrier and separating agent for rapid dissolution.
Chitosan mediates decursinol solubility to inhibit vascular smooth muscle cell proliferation.
Non-ionic surfactants form micellar assemblies that solubilize lipophilic natural compounds, overcoming poor gastrointestinal absorption.
Segmented beads with HPMCAS coatings resolve the contradiction between ease of oral administration and chemical stability in acidic media.
Ethanol and glycerine solubilize nifedipine in an oral liquid composition, eliminating polyethylene glycol toxicity risks while improving bioavailability.
Inhaled molgramostim replaces invasive whole lung lavage to treat autoimmune pulmonary alveolar proteinosis without anesthesia morbidity.
Micro-fibrillated cellulose serves as the exclusive disintegrator, enabling 80-90 wt% active ingredient concentration while maintaining tablet hardness.
Using an acidic soft drink at pH 2 to 3.5 optimizes prolyl endopeptidase catalysis, reducing required enzyme doses and alleviating gastrointestinal discomfort.
A solid drink formulation combines multiple herbal extracts with food-grade carriers to create a palatable health product.
A portable vaporization system uses a calibrated heating element to generate smokeless cannabinoid aerosols from interchangeable cartridges.
An optimized aerosol solution uses 1M HCl and ethanol to stabilize glycopyrronium bromide and formoterol, preventing degradation and extending shelf-life.
Mucin-interacting agents form an in-situ physical barrier in the duodenum to disrupt neurohormonal signaling pathways.
A pH buffering system maintains a 4 to 8 range to protect GLP-1 receptor agonists from pepsin degradation during oral administration.
Heat-activated Bacillus spores bypass harsh gastric conditions to colonize the intestine, reducing C-reactive protein levels.
A powder formulation combines alpha-lactalbumin and maltodextrins to bind butyric acid salts.
A nanoemulsion composition delivers aeroallergens to modulate immune responses and reduce airway inflammation.